✦ LIBER ✦

PGI17 HCV TREATMENT CONTINUATION RATES IN GENOTYPE 1 PATIENTS IN A REAL-WORLD SETTING IN THE UNITED STATES

✍ Scribed by J. Diels; S. Gavart; G. Nuyts

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN87 Hepatitis C Treatment Continuation

✍ F. Mussolino; P. Vaz; A.D. Morais; M.L. Pereira 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

P1150 BASELINE CHARACTERISTICS AND TREAT

✍ Hofmann, W.P.; Mauss, S.; Baumgarten, A.; Boeker, K.H.W.; Link, R.; Naumann, U.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P1137 TREATMENT OF CHRONIC HCV GENOTYPE

✍ Buggisch, P.; Löhr, H.; Teuber, G.; Steffens, H.; Kraus, M.R.; John, C.; Geyer, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P739 RISK FACTORS AND TREATMENT OUTCOMES

✍ Moreno, C.; Horsmans, Y.; Flisiak, R.; Van Vlierberghe, H.; Trepo, E.; Starkel, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 67 KB

1164 HEMOGLOBINE DECLINE DURING PEGINTER

✍ Teuber, G.; Mauss, S.; Hüppe, D.; Zehnter, E.; Manns, M.P.; Dahhan, T.; Meyer, U 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Clinical and economic burden of veteran

✍ Wang, L.; Zhang, J.; Li, L.; Baser, O. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB